Insider trades

Brian Lian, CEO of Viking Therapeutics VKTX, has filed 0 purchases and 35 sales on the open market. Over the past 12 months that comes to a net sale of $9.1M. The latest trade was on 01/05.

Brian Lian

President & CEO
First filing
23/01/04
Trades
90 trades
Buys / sales
0 / 35
12-month net buying
−$9.1M
Last trade
01/05

Trading activity

Transactions

Trade type
VKTX
Open-market sale01/0501/05233,409 sh4 trades$32.96avg.$7,692,305.4−8.5%
Open-market sale25/10/2825/10/2838,989 sh$35.01$1,365,004.89−1.6%
Open-market sale25/07/0325/07/0326,889 sh$27.80$747,514.2−1.1%
VKTX
Open-market sale25/01/0625/01/06194,490 sh2 trades$42.74avg.$8,312,993.2−7.6%
VKTX
Open-market sale10b5-1 plan24/09/2024/09/20216,130 sh3 trades$70.83avg.$15,308,657.18−8.6%
Open-market sale10b5-1 plan24/08/2124/08/221,000 sh$69.90$69,900−0.0%
VKTX
Open-market sale10b5-1 plan24/08/1924/08/19112,870 sh3 trades$65.80avg.$7,426,716.62−4.6%
VKTX
Open-market sale24/07/3024/07/31115,859 sh3 trades$57.58avg.$6,670,604.02−4.7%
Open-market sale10b5-1 plan24/02/0924/02/0945,000 sh$29.90$1,345,500−2.1%
VKTX
Open-market sale10b5-1 plan24/02/0824/02/08269,079 sh5 trades$26.87avg.$7,230,784.25−11.0%
VKTX
Open-market sale10b5-1 plan24/01/3124/01/3185,000 sh2 trades$24.71avg.$2,100,750−3.6%
Open-market sale10b5-1 plan24/01/3024/01/3035,000 sh$23.95$838,250−1.5%
Open-market sale23/05/0123/05/0145,000 sh$22.45$1,010,250−2.0%
Open-market sale23/04/1923/04/2135,000 sh$21.45$750,750−1.5%
Open-market sale23/04/1723/04/18155,000 sh$20.45$3,169,750−6.4%
Open-market sale23/04/1323/04/1379,336 sh$18.45$1,463,749.2−3.3%
VKTX
Open-market sale23/03/30–23/04/0323/04/03243,352 sh4 trades$17.31avg.$4,211,292.4−9.8%